Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
about
Medical management of epileptic seizures: challenges and solutionsVirologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.Editorial neuroAIDS review.Role of anticonvulsants in the management of AIDS related seizures.Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells.
P2860
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
@ast
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
@en
type
label
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
@ast
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
@en
prefLabel
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
@ast
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
@en
P2093
P2860
P356
P1433
P1476
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
@en
P2093
Ferdinand Maingat
Hartmut B Krentz
Pornpun Vivithanaporn
Reed A Siemieniuk
P2860
P2888
P356
10.1186/1471-2377-10-44
P577
2010-06-17T00:00:00Z
P5875
P6179
1030232858